secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCTAVE SPECIALTY GROUP INC (OSG)
CIK:        0000874501
Form:       8-K
Filed at:   2026-02-23T23:59:59+00:00
Accession:  0001628280-26-010639
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Octave Specialty Q4 2025: Net loss from continuing ops $29.98M, adjusted EBITDA improves to $1.35M
--------------------------------------------------------------------------------

- Revenue $66.9M (+3% YoY); net loss from continuing ops to shareholders $29.98M (diluted EPS -$0.84) vs loss $22.16M (EPS -$0.56) last Q4.
- Insurance Distribution: premium production $303M (+15%), commission income $37M (+13%), organic growth 8.1%, segment adjusted EBITDA $7M (+33%).
- Everspan: gross premiums written $80M (+34%), net premiums written $23M (+978%), combined ratio below 100%, net income fell 37% to $1M.
- Adjusted EBITDA to shareholders $1.35M vs $0.52M; driven by ID segment improvement and corporate cost reductions.
- Acquired ArmadaCare and launched 1889 Specialty MGA in Q4; expects strong organic growth in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874501/000162828026010639/0001628280-26-010639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874501/000162828026010639/ambc-20260223.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-010639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer